Kilitch Drugs (India) Ltd
company logo

Kilitch Drugs (India) Ltd

Kilitch Drugs Share Price

Pharmaceuticals
Small Cap

-

0 (0%)


Invest in Kilitch Drugs (India) Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Kilitch Drugs (India) Ltd Performance

-

-

-

-


-

-

-

-

-

Kilitch Drugs (India) Ltd Fundamentals

Read More

497.02Cr

30.18

2.63

0.16

10.24

0%

117.72

Kilitch Drugs (India) Ltd Financials

Kilitch Drugs (India) Ltd Financialsright-arrow

Kilitch Drugs (India) Ltd Shareholding Pattern

Kilitch Drugs (India) Ltd Delivery and Volume

About Kilitch Drugs (India) Ltd

Kilitch Drugs (India) Limited (KDIL) was incorporated in May, 1992 as a public limited company. The Company is a pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. The Company is one of the most reliable manufacturer of injectables in India and on

Mukund P Mehta

1992

KILITCH

NameDesignation
Mukund P MehtaManaging Director
Bhavin M MehtaWhole-time Director
Hemang EngineerIndependent Director
Mira Bhavin MehtaWhole-time Director
Murti Vasudev KrishnaIndependent Director
Venkita Subramanian RajanIndependent Director
Pushpa NyoupaneCompany Sec. & Compli. Officer
News and Events...

Similar Stocks

What's Trending

View All
View All

Kilitch Drugs (India) Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Kilitch Drugs (India) Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Kilitch Drugs (India) Ltd's share price is ₹310.05 as of 2024-11-23.
Kilitch Drugs (India) Ltd's P/E ratio is 30.18 times as of 2024-11-23.
Kilitch Drugs (India) Ltd's most recent financial reports indicate a price-to-book ratio of 2.63, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Kilitch Drugs (India) Ltd's market capitalization is ₹497.02 Cr as on 2024-11-23.
The current financial records of Kilitch Drugs (India) Ltd show a 8.39% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Kilitch Drugs (India) Ltd's most recent financial filings, the company has a total asset value of ₹94.62, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Kilitch Drugs (India) Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Kilitch Drugs (India) Ltd's 52-week high and low as of 2024-11-23 are ₹316.9 and ₹304.2, respectively.